Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative biolabs has developed Lentiviral CAR vector pCDCAR1 CD317 (HM1.24) h(ICOSBB_), which is constructed for the engineering of T cells to target human CD317. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-CD317 antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of breast, lung, kidney, endometrial and skin cancer.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.